Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT-DCM
NCT00765518Phase 2Completed
- Sponsor
- Vericel
- Start
- Sep 2008
- Primary completion
- Sep 2012
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ixmyelocel-T in dilated cardiomyopathy (DCM), sponsored by Vericel. Started Sep 2008; status: completed.
02
Drugs
ixmyelocel-T
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT00765518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765518.